Biotalys

Biotalys Current Assets

The Current Assets of Biotalys (BTLS.BR) as of Oct 30, 2026 is 11.40 M EUR. In the previous year, Current Assets was 26.78 M EUR — a change of -57.43% (lower).

Current Assets

11.40 MEUR

YoY

-57.43%

Last updated:

Current Assets of Biotalys is 2025 11.40 M EUR. Current Assets of Biotalys was 2024 26.78 M EUR. It decreases by -57.43% lower compared to the previous year.

The Biotalys Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
8.27 M EUR
Jan 1, 2019
24.37 M EUR
Jan 1, 2020
25.74 M EUR
Jan 1, 2021
59.39 M EUR
Jan 1, 2022
38.58 M EUR
Jan 1, 2023
25.66 M EUR
Jan 1, 2024
26.78 M EUR
Jan 1, 2025
11.40 M EUR
The Biotalys Current Assets history
YEARCurrent AssetsYoY
11.40 MEUR-57.43%
26.78 MEUR+4.35%
25.66 MEUR-33.49%
38.58 MEUR-35.03%
59.39 MEUR+130.77%
25.74 MEUR+5.61%
24.37 MEUR+194.54%
8.27 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biotalys Stock analysis

What does Biotalys do? Biotalys NV develops sustainable crop protection products, including AGROBODY Foundry, which combines active ingredients with Agrobodies as formulation agents. The company offers protein-based biocontrol solutions targeting crop pests and diseases, with a product pipeline called EvocaTM addressing key agricultural threats. Biotalys provides tools to prevent crop loss, extend post-harvest protection, and reduce food waste through its BioFungicides, BioInsecticides, and BioBactericides product lines. The company generates revenue by selling its crop protection products to agricultural stakeholders, including farmers and agribusinesses seeking sustainable pest management solutions. AGROBODY Foundry and EvocaTM are key products driving sales, while BioFungicides, BioInsecticides, and BioBactericides form the core of its product portfolio. Biotalys focuses on delivering biocontrol solutions that tackle a wide range of crop pests and diseases, appealing to environmentally conscious agricultural sectors. Biotalys' business model centers on developing and commercializing bio-based crop protection technologies. Its product pipeline, including EvocaTM and the three biocontrol categories, targets the growing market for sustainable agricultural practices. The company monetizes its technology through direct sales of its branded products to end-users in the agricultural industry, emphasizing eco-friendly alternatives to conventional pesticides. Biotalys is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biotalys stock

Current Assets of Biotalys is 11.40 M EUR in 2025.

Current Assets of Biotalys changed from 26.78 M EUR to 11.40 M EUR, representing a -57.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Biotalys since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Biotalys historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Biotalys

All Key Metrics — Biotalys